Just as newly-approved vaccines begin to offer the prospect of a return to normalcy, the emergence of broadly-circulating SARS-CoV-2 variants has raised significant concerns about vaccine efficacy.1-3
This new white paper discusses the differences between mutants, variants, and strains, and how they might affect SARS-CoV-2 antigen testing. Learn about Variants of Concern (VOCs) and how enhanced surveillance supports earlier identification.
Because of their increased risk to public health, Siemens Healthineers is committed to the continuous monitoring of emerging variants and conducting evaluations to help ensure that our assays remain effective at detecting them. Our SARS-CoV-2 Antigen assay features antibodies that maximize variant detection, including the rapidly-spreading Delta and Omicron variants.